{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:34:58Z","timestamp":1759541698873},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute (NCI)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Clinical Trials Network (NCTN)","award":["CA180888","CA180819","CA180801","CA180835","CA180828","CA180846"],"award-info":[{"award-number":["CA180888","CA180819","CA180801","CA180835","CA180828","CA180846"]}]},{"name":"NIH\/NCI SWOG Biorepository","award":["CA114748"],"award-info":[{"award-number":["CA114748"]}]},{"name":"NCI Community Oncology Research Program (NCORP)","award":["CA189848","CA045807","CA189856","CA189853","CA189808","CA189858","CA189860","CA189971","CA189954","CA189872"],"award-info":[{"award-number":["CA189848","CA045807","CA189856","CA189853","CA189808","CA189858","CA189860","CA189971","CA189954","CA189872"]}]},{"name":"Celgene Corporation and Pfizer, Inc."}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.leukres.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T17:17:33Z","timestamp":1452878253000},"page":"68-74","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients"],"prefix":"10.1016","volume":"42","author":[{"given":"Nicholas J.","family":"Achille","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Othus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrine","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald P.","family":"Radich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry P.","family":"Erba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sucha","family":"Nand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy J.","family":"Zeleznik-Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (9)","key":"10.1016\/j.leukres.2016.01.004_bib0005","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"issue":"June (5)","key":"10.1016\/j.leukres.2016.01.004_bib0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2141.2009.07663.x","article-title":"Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials","volume":"145","author":"Wheatley","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"September (13)","key":"10.1016\/j.leukres.2016.01.004_bib0015","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"High-dose daunorubicin in older patients with acute myeloid leukemia","volume":"361","author":"Lowenberg","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"October (17)","key":"10.1016\/j.leukres.2016.01.004_bib0020","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2010-05-260117","article-title":"How I treat acute myeloid leukemia","volume":"116","author":"Rowe","year":"2010","journal-title":"Blood"},{"issue":"December","key":"10.1016\/j.leukres.2016.01.004_bib0025","first-page":"24","article-title":"G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm","author":"Becker","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"April (8)","key":"10.1016\/j.leukres.2016.01.004_bib0030","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood.V91.8.2985.2985_2985_2990","article-title":"Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression","volume":"91","author":"Quesnel","year":"1998","journal-title":"Blood"},{"issue":"October (16)","key":"10.1016\/j.leukres.2016.01.004_bib0035","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1182\/blood-2009-01-200519","article-title":"MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation","volume":"114","author":"Figueroa","year":"2009","journal-title":"Blood"},{"issue":"June (5)","key":"10.1016\/j.leukres.2016.01.004_bib0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bjh.12811","article-title":"CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression","volume":"165","author":"Zhao","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"March (3)","key":"10.1016\/j.leukres.2016.01.004_bib0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/leu.2013.343","article-title":"Epigenetics of myelodysplastic syndromes","volume":"28","author":"Itzykson","year":"2014","journal-title":"Leukemia"},{"issue":"September (5)","key":"10.1016\/j.leukres.2016.01.004_bib0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bjh.12957","article-title":"Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution","volume":"166","author":"Bravo","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"October (4)","key":"10.1016\/j.leukres.2016.01.004_bib0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.seminhematol.2012.08.001","article-title":"Clinical results with the DNA hypomethylating agent 5-aza-2\u2032-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update","volume":"49","author":"Joeckel","year":"2012","journal-title":"Semin. Hematol."},{"issue":"September (5)","key":"10.1016\/j.leukres.2016.01.004_bib0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.blre.2013.07.003","article-title":"Current therapy of myelodysplastic syndromes","volume":"27","author":"Zeidan","year":"2013","journal-title":"Blood Rev."},{"issue":"June (12)","key":"10.1016\/j.leukres.2016.01.004_bib0065","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1158\/0008-5472.CAN-06-0080","article-title":"Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms","volume":"66","author":"Gore","year":"2006","journal-title":"Cancer Res."},{"issue":"May (10)","key":"10.1016\/j.leukres.2016.01.004_bib0070","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1158\/0008-5472.CAN-05-2385","article-title":"DNA methylation changes after 5-aza-2\u2032-deoxycytidine therapy in patients with leukemia","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"issue":"January (1)","key":"10.1016\/j.leukres.2016.01.004_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccr.2009.11.020","article-title":"DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia","volume":"17","author":"Figueroa","year":"2010","journal-title":"Cancer Cell."},{"issue":"August (35)","key":"10.1016\/j.leukres.2016.01.004_bib0080","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","article-title":"DNA methylation in cancer: too much, but also too little","volume":"21","author":"Ehrlich","year":"2002","journal-title":"Oncogene"},{"issue":"Febueary (2)","key":"10.1016\/j.leukres.2016.01.004_bib0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/72785","article-title":"Aberrant CpG-island methylation has non-random and tumour-type-specific patterns","volume":"24","author":"Costello","year":"2000","journal-title":"Nat. Genet."},{"issue":"June (6)","key":"10.1016\/j.leukres.2016.01.004_bib0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.leukres.2004.11.014","article-title":"Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia","volume":"29","author":"Shimamoto","year":"2005","journal-title":"Leuk. Res."},{"issue":"May (5)","key":"10.1016\/j.leukres.2016.01.004_bib0095","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ijc.20797","article-title":"Tamm I. 5-Aza-2\u2032-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia","volume":"114","author":"Schmelz","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"June (6)","key":"10.1016\/j.leukres.2016.01.004_bib0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1158\/1541-7786.MCR-04-0105","article-title":"Methylation silencing of the Apaf-1 gene in acute leukemia","volume":"3","author":"Furukawa","year":"2005","journal-title":"Mol. Cancer Res."},{"issue":"May (10)","key":"10.1016\/j.leukres.2016.01.004_bib0105","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1182\/blood.V95.10.3208","article-title":"Hypermethylation of E-cadherin in leukemia","volume":"95","author":"Melki","year":"2000","journal-title":"Blood"},{"issue":"August (15)","key":"10.1016\/j.leukres.2016.01.004_bib0110","first-page":"3730","article-title":"Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia","volume":"59","author":"Melki","year":"1999","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.leukres.2016.01.004_bib0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4149\/neo_2012_022","article-title":"Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia","volume":"59","author":"Cechova","year":"2012","journal-title":"Neoplasma"},{"issue":"September (12)","key":"10.1016\/j.leukres.2016.01.004_bib0120","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2012-05-429175","article-title":"Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia","volume":"120","author":"Yan","year":"2012","journal-title":"Blood"},{"issue":"November (32)","key":"10.1016\/j.leukres.2016.01.004_bib0125","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1200\/JCO.2012.42.2964","article-title":"Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia","volume":"30","author":"Burnett","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"April (9825)","key":"10.1016\/j.leukres.2016.01.004_bib0130","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(12)60485-1","article-title":"Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study","volume":"379","author":"Castaigne","year":"2012","journal-title":"Lancet"},{"issue":"June (24)","key":"10.1016\/j.leukres.2016.01.004_bib0135","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1182\/blood-2013-01-466706","article-title":"A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia","volume":"121","author":"Petersdorf","year":"2013","journal-title":"Blood"},{"issue":"Feburary (4)","key":"10.1016\/j.leukres.2016.01.004_bib0140","doi-asserted-by":"crossref","first-page":"916","DOI":"10.18632\/oncotarget.1536","article-title":"Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial","volume":"5","author":"Renneville","year":"2014","journal-title":"Oncotarget"},{"issue":"Feburary (2)","key":"10.1016\/j.leukres.2016.01.004_bib0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/annonc\/mdt566","article-title":"Effect of adding gemtuzumab ozogamicin to induction chemotherapy for newly diagnosed acute myeloid leukemia: a meta-analysis of prospective randomized phase III trials","volume":"25","author":"Li","year":"2014","journal-title":"Ann. Oncol."},{"issue":"August (9)","key":"10.1016\/j.leukres.2016.01.004_bib0150","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1470-2045(14)70281-5","article-title":"Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials","volume":"15","author":"Hills","year":"2014","journal-title":"Lancet Oncol."},{"issue":"November (20)","key":"10.1016\/j.leukres.2016.01.004_bib0155","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2013-06-506592","article-title":"A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia","volume":"122","author":"Nand","year":"2013","journal-title":"Blood"},{"issue":"December (4)","key":"10.1016\/j.leukres.2016.01.004_bib0160","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394ct method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"Feburary (2)","key":"10.1016\/j.leukres.2016.01.004_bib0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.leukres.2012.10.015","article-title":"Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia","volume":"37","author":"Claus","year":"2013","journal-title":"Leuk. Res."},{"issue":"May (22)","key":"10.1016\/j.leukres.2016.01.004_bib0170","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.leukres.2016.01.004_bib0175","doi-asserted-by":"crossref","first-page":"e54365","DOI":"10.1371\/journal.pone.0054365","article-title":"Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases","volume":"8","author":"Fasan","year":"2013","journal-title":"PLoS One"},{"issue":"May (21)","key":"10.1016\/j.leukres.2016.01.004_bib0180","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1182\/blood-2013-07-512855","article-title":"Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling","volume":"123","author":"Taskesen","year":"2014","journal-title":"Blood"},{"issue":"October (2)","key":"10.1016\/j.leukres.2016.01.004_bib0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bjh.12029","article-title":"DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups","volume":"159","author":"Ohgami","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"June (6)","key":"10.1016\/j.leukres.2016.01.004_bib0190","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/bjc.1993.241","article-title":"Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells","volume":"67","author":"Baer","year":"1993","journal-title":"Br. J. Cancer"},{"issue":"January (1)","key":"10.1016\/j.leukres.2016.01.004_bib0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.22191","article-title":"Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia","volume":"87","author":"Medeiros","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"June (25)","key":"10.1016\/j.leukres.2016.01.004_bib0200","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","article-title":"MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1","volume":"113","author":"Garzon","year":"2009","journal-title":"Blood"},{"issue":"April (16)","key":"10.1016\/j.leukres.2016.01.004_bib0205","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.1002650107","article-title":"Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine","volume":"107","author":"Blum","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T01:26:07Z","timestamp":1600046767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616300042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":41,"alternative-id":["S0145212616300042"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.01.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}